SeQuent® SCB "All Comers" Post Market Clinical Follow-up (PMCF)
| Kurzfassung |
This study is a single armed, prospective, multi-center, observational study Planned: up to 40 study sites in the EU and selected non-EU-countries |
| Art des Forschungsprojektes | Klinische Forschung |
| Status | Laufend - Rekrutierungsphase |
| Projektstart | 2021 |
| Projektende | 2025 |
| Studiendesign | This study is a single armed, prospective, multi-center, observational study |
| Verantwortliche Person / Hauptprüfarzt am KSSG | Dr.D.Weilenmann |